Apart from hematological malignancies and NSCLC, CD27 expression was detected in tumor bearing mice ([9]; RCC ([10]; [44] and nasopharyngeal carcinoma [19] among other cancers [15]. This evidence concerns the gene CD27 and nasopharyngeal carcinoma.